$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000162828016021005 Filed on November 08, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$240.1M	$224.5M	$247.2M
YoY Change	-1.49%	-9.17%	1.34%
Cost Of Revenue	$169.0M	$162.0M	$182.0M
YoY Change	-1.23%	-11.01%	6.62%
Gross Profit	$73.79M	$61.72M	$65.23M
YoY Change	11.96%	-5.38%	4.06%
Gross Profit Margin	30.73%	27.49%	26.39%
Selling, General & Admin	$15.40M	$17.70M	$17.90M
YoY Change	-68.76%	-1.12%	-78.22%
% of Gross Profit	20.87%	28.68%	27.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.000M	$4.200M	$4.029M
YoY Change	73.08%	4.24%	-4.19%
% of Gross Profit	12.2%	6.8%	6.18%
Operating Expenses	$60.80M	$64.50M	$65.60M
YoY Change	-10.32%	-1.68%	-21.62%
Operating Profit	$12.99M	-$2.779M	-$19.28M
YoY Change	-787.1%	-85.59%	-30.4%
Interest Expense	-$9.400M	-$9.300M	-$9.500M
YoY Change	-2.08%	-2.11%	-199.34%
% of Operating Profit	-72.35%
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.064M	-$11.01M	-$28.79M
YoY Change	-74.57%	-61.75%	-22.76%
Income Tax	$1.400M	$421.0K	-$4.551M
% Of Pretax Income
Net Earnings	-$12.86M	-$11.33M	-$16.78M
YoY Change	-30.28%	-32.51%	-56.64%
Net Earnings / Revenue	-5.35%	-5.04%	-6.79%
Basic Earnings Per Share
Diluted Earnings Per Share	-$464.4K	-$393.7K	-$976.7K
COMMON SHARES
Basic Shares Outstanding	117.7M shares	113.9M shares	68.73M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.600M	$2.800M	$29.40M
YoY Change	-38.46%	-90.48%
Cash & Equivalents	$9.569M	$2.835M	$29.44M
Short-Term Investments
Other Short-Term Assets	$18.50M	$19.50M	$21.90M
YoY Change	-33.45%	-10.96%	97.3%
Inventory	$36.17M	$33.38M	$26.89M
Prepaid Expenses
Receivables	$109.1M	$103.7M	$121.2M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$173.3M	$159.4M	$199.4M
YoY Change	-5.64%	-20.08%	-7.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.68M	$33.71M	$34.11M
YoY Change	2.31%	-1.16%	-14.84%
Goodwill	$365.9M	$373.1M	$308.7M
YoY Change	18.53%	20.84%	-46.15%
Intangibles	$31.04M
YoY Change	505.36%
Long-Term Investments
YoY Change
Other Assets	$1.990M	$2.055M	$1.158M
YoY Change	71.4%	77.46%	-9.18%
Total Long-Term Assets	$431.7M	$436.0M	$363.2M
YoY Change	24.41%	20.04%	-43.53%
TOTAL ASSETS
Total Short-Term Assets	$173.3M	$159.4M	$199.4M
Total Long-Term Assets	$431.7M	$436.0M	$363.2M
Total Assets	$605.0M	$595.4M	$562.7M
YoY Change	14.01%	5.82%	-34.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$64.42M	$45.70M	$53.38M
YoY Change	-1.01%	-14.39%	-28.68%
Accrued Expenses	$43.50M	$43.10M	$50.40M
YoY Change	-27.26%	-14.48%	26.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$18.52M	$48.20M	$39.60M
YoY Change	-24.03%	21.72%	708.16%
Total Short-Term Liabilities	$130.1M	$140.9M	$146.8M
YoY Change	-14.81%	-4.03%	8.35%
LONG-TERM LIABILITIES
Long-Term Debt	$433.4M	$388.1M	$409.3M
YoY Change	10.08%	-5.18%	-2.17%
Other Long-Term Liabilities	$763.0K	$4.502M	$6.793M
YoY Change	-59.0%	-33.73%	-17.71%
Total Long-Term Liabilities	$763.0K	$4.502M	$6.793M
YoY Change	-59.0%	-33.73%	-17.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$130.1M	$140.9M	$146.8M
Total Long-Term Liabilities	$763.0K	$4.502M	$6.793M
Total Liabilities	$566.6M	$550.1M	$563.0M
YoY Change	3.28%	-2.3%	-2.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$645.3M	-$630.9M	-$583.5M
YoY Change	7.21%	8.14%	144.56%
Common Stock	$611.7M	$606.7M	$533.1M
YoY Change	15.03%	13.81%	1.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$0.00	$10.74M
YoY Change	-100.0%	-100.0%	4.13%
Treasury Stock Shares	0.000 shares	0.000 shares	2.654M shares
Shareholders Equity	$600.8M	-$24.28M	-$61.14M
YoY Change
Total Liabilities & Shareholders Equity	$605.0M	$595.4M	$562.7M
YoY Change	14.01%	5.82%	-34.49%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	-$12.86M	-$11.33M	-$16.78M
YoY Change	-30.28%	-32.51%	-56.64%
Depreciation, Depletion And Amortization	$9.000M	$4.200M	$4.029M
YoY Change	73.08%	4.24%	-4.19%
Cash From Operating Activities	-$4.000M	-$16.90M	-$20.40M
YoY Change	-310.53%	-17.16%	2814.29%
INVESTING ACTIVITIES
Capital Expenditures	-$1.900M	-$2.500M	-$4.300M
YoY Change	35.71%	-41.86%	-2.27%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$64.40M	$22.40M
YoY Change	-100.0%	-387.5%
Cash From Investing Activities	-$1.800M	-$67.10M	$18.00M
YoY Change	-325.0%	-472.78%	-509.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.50M	35.40M	30.70M
YoY Change	-175.76%	15.31%	752.78%
NET CHANGE
Cash From Operating Activities	-4.000M	-16.90M	-20.40M
Cash From Investing Activities	-1.800M	-67.10M	18.00M
Cash From Financing Activities	12.50M	35.40M	30.70M
Net Change In Cash	6.700M	-48.60M	28.30M
YoY Change	-148.55%	-271.73%	-1986.67%
FREE CASH FLOW
Cash From Operating Activities	-$4.000M	-$16.90M	-$20.40M
Capital Expenditures	-$1.900M	-$2.500M	-$4.300M
Free Cash Flow	-$2.100M	-$14.40M	-$16.10M
YoY Change	-163.64%	-10.56%	-535.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	4597000	USD
CY2015Q3	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-51000	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	21000	USD
CY2016Q3	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	4699000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	9326000	USD
CY2015Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3491000	USD
CY2016Q3	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3953000	USD
CY2015Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	52918000	USD
CY2016Q3	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	40804000	USD
CY2015Q3	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	5368000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	15041000	USD
CY2016Q3	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	2368000	USD
	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	-784000	USD
	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	3954000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	-1354000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	461000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	21000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	4597000	USD
	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	59691000	USD
	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	0	USD
CY2015Q3	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	1100000	USD
CY2016Q2	bios	Saleof Stock Equity Issuable Amount SaleofStockEquityIssuableAmount	200000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.20
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	450000	USD
	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	117682543	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	65077000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	45700000	USD
CY2015Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	157042000	USD
CY2016Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	154760000	USD
CY2015Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	97353000	USD
CY2016Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	103688000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	531764000	USD
CY2016Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	606656000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59689000	USD
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	51072000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59689000	USD
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	51072000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2929000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3005000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5473000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17517000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4166000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12956000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6300000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6200000	shares
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14500000	shares
CY2015Q4	us-gaap	Assets Assets	530642000	USD
CY2016Q3	us-gaap	Assets Assets	595401000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	183685000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	159365000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	15812000	USD
CY2015Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	274000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	753000	USD
CY2016Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4695000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	7619000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	740000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29441000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15577000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2835000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	28701000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-12742000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	22375000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	4061000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5172000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	181991000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	543472000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	161957000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	504485000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-22594000	USD
CY2016Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	303000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-6088000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71421664	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117682543	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68767613	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117682543	shares
CY2015Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	19000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	50000	USD
CY2016Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	118000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	143000	USD
CY2015Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	19000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	50000	USD
CY2016Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	118000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	143000	USD
CY2015Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3803000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-19290000	USD
CY2016Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	268000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	393000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15863000	USD
CY2016Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	13325000	USD
CY2015Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4570000	USD
CY2015Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-767000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3304000	USD
CY2016Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	35000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	57000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	236000	USD
CY2016Q3	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	773000	USD
	us-gaap	Depreciation Depreciation	17517000	USD
	us-gaap	Depreciation Depreciation	12956000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-28576000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9948000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30413000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	308729000	USD
CY2016Q3	us-gaap	Goodwill Goodwill	373070000	USD
CY2015Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13850000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	251850000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.39
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-4.28
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.12
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.42
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	7698000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5128000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27201000	USD
CY2015Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5000	USD
CY2016Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3015000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3954000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8547000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31881000	USD
CY2016Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	65233000	USD
	us-gaap	Gross Profit GrossProfit	195006000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	62585000	USD
	us-gaap	Gross Profit GrossProfit	190981000	USD
CY2015Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	247224000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	738478000	USD
CY2016Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	224542000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	695466000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-24479000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-286436000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11090000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-29169000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-29030000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-308980000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10669000	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-174000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	134000	USD
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.11
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.08
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4629000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10328000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12802000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4551000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22544000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	421000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	593000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4715000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	42501000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4967000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10282000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11275000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-108143000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3730000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10002000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	2385000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	43362000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	70000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	171000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-947000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	179000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-446000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-435000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	131000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	134000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	462000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	260000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-35822000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-31248000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	21208000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-536000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4586000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8555000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-7841000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3386000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9161000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3623000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-6720000	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9506000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-27750000	USD
CY2016Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9331000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28212000	USD
	us-gaap	Interest Paid Net InterestPaidNet	23882000	USD
	us-gaap	Interest Paid Net InterestPaidNet	30128000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6898000	USD
CY2016Q3	us-gaap	Interest Payable Current InterestPayableCurrent	2268000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	42983000	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	33380000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	548602000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	550053000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	530642000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	595401000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	152764000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	140914000	USD
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	409851000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-11264000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	393741000	USD
CY2016Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	388052000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	24380000	USD
CY2016Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	48189000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	418121000	USD
CY2016Q3	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	436241000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83097000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	97179000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29035000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18849000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-288940000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13575000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-35745000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	3750000	shares
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12229000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-71383000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-10146000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-71383000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66625000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38538000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-70686000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-32450000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-16781000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-281264000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1161000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2055000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1861000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4502000	USD
CY2015Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	42155000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	127120000	USD
CY2016Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	42729000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	123006000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1219000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	7133000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	67516000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10146000	USD
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4175000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8044000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4175000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27772000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19462000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	83267000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	203663000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	84000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-60000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-152000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-9411000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4177000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31939000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33710000	USD
CY2015Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9366000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	32832000	USD
CY2016Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7727000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19598000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	97353000	USD
CY2016Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	103688000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	315000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	525000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	178663000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	60000000	USD
CY2015Q3	us-gaap	Restructuring Charges RestructuringCharges	5043000	USD
	us-gaap	Restructuring Charges RestructuringCharges	14309000	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	2372000	USD
	us-gaap	Restructuring Charges RestructuringCharges	6304000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-601913000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-630948000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3651000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3347000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	9938000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-80878000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	-24280000	USD
CY2015Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	169000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3519000	USD
CY2016Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	173000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	518000	USD
CY2015Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1899000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4157000	USD
CY2016Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2138000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	6192000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2654051	shares
CY2016Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10737000	USD
CY2016Q3	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68742000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68693000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	114826000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	85701000	shares

Files In Submission

Name	View Source	Status
0001628280-16-021005-index-headers.html	Edgar Link	pending
0001628280-16-021005-index.html	Edgar Link	pending
0001628280-16-021005.txt	Edgar Link	pending
0001628280-16-021005-xbrl.zip	Edgar Link	pending
bios-20160930.xml	Edgar Link	completed
bios-20160930.xsd	Edgar Link	pending
bios-20160930x10q.htm	Edgar Link	pending
bios-20160930_cal.xml	Edgar Link	unprocessable
bios-20160930_def.xml	Edgar Link	unprocessable
bios-20160930_lab.xml	Edgar Link	unprocessable
bios-20160930_pre.xml	Edgar Link	unprocessable
bios-ex311x20160930x10q.htm	Edgar Link	pending
bios-ex312x20160930x10q.htm	Edgar Link	pending
bios-ex321x20160930x10q.htm	Edgar Link	pending
bios-ex322x20160930x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logowithregisteredtm04.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2016 Q4 Form 10-Q Financial Statement

#000162828016021005 Filed on November 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2016 Q4 Form 10-Q Financial Statement

#000162828016021005 Filed on November 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch